Alameda, United States
iota Biosciences, Inc. powered by Astellas is a cutting-edge medical device company within the Astellas Pharma US group, founded in 2017. With its headquarters in the United States, iota Biosciences is innovatively using breakthrough ultrasound technology from the University of California, Berkeley, aiming to revolutionize the biotechnology and life sciences industries.
The company is renowned for advancing diagnostic and therapeutic bioelectronics, with a mission to improve the way diseases are treated and managed. The support from Astellas, a leading global pharmaceutical entity, enhances its ability to reach a broader audience and tackle complex healthcare challenges with a transformational vision.
In their last investment round on December 27, 2018, iota Biosciences secured a $15.00M Series A investment led by various prominent investors like Ironfire Ventures, The House Fund, Horizons Ventures, and Astellas Pharma, reflecting strong confidence in their future potential.
Cogentis Therapeutics, Inc.